CRisP is a translational research environment at one of the world’s leading medical universities, Karolinska Institutet. Through a cross-disciplinary and collaborative approach, focusing on individualized cancer risk prediction and prevention, we develop strategies that decrease the mortality of breast and prostate cancer.
We know that cancer mortality can be reduced if cases are detected and treated early, but there is a problem with over-diagnosis and over-treatment. What if we instead could predict the risk for aggressive cancers? Our research focuses on understanding cancer risk and how to design individualized prevention strategies.
Read more about our research.